Skip to main content

Table 1 PICOS statement for inclusion and exclusion criteria

From: Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis

  Inclusion Criteria Exclusion Criteria
Study population Schizophrenia patients, regardless of their age, sex, ethnic group or disease status. Any not listed in the inclusion criteria
Intervention Amisulpride in any oral form of application with any dose Any not listed in the inclusion criteria
Comparator Olanzapine in any oral form of application with any dose Any not listed in the inclusion criteria
Outcome measures Clinical efficacy outcomes
Safety outcome
Any not listed in the inclusion criteria
Study design RCTs with head-to-head comparison Editorials OR Notes OR Comments OR Letters OR Case reports OR Pharmacokinetic studies OR Epidemiology studies
Restrictions Full-text published manuscripts in English or Chinese
Year limitation: no limit
Duplicates
Not full-text published manuscripts
Non-English or non-Chinese studies